Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Researchers used evolutionary genetics and CRISPR gene editing tech to develop an innovative treatment for gout. The approach ...

In the race to uncover the genetic drivers of disease, running a CRISPR screen is only half the battle. The real challenge begins when terabytes of next-generation sequencing (NGS) data arrive, and ...

91%客观缓解率的背后，是CRISPR基因编辑技术对免疫细胞"同族相残"魔咒的彻底打破 在全球细胞治疗领域因CAR-T在B细胞血液肿瘤中的成功而欢呼时，一个顽固的堡垒依然久攻不下——T细胞恶性肿瘤。当患者自身的T细胞已成为“叛军”，如何再用它们制造“平叛军队”？即使造出军队，它们是否会在执行任务前就“自相残杀”？ 美国生物科技公司Wugen用一项突破性的技术设计和1.15亿美元的最新融资，给出了自 ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free ...

CRISPR Therapeutics is the first company to secure an FDA approval of a gene-editing drug. That drug's underlying science, however, could be used to create treatments for any number of genetically ...

The American Cancer Society awarded 14 new Discovery Boost grants and 4 new Mission Boost grants across 17 institutions this ...

One town’s effort to make pricey items accessible and encourage people to buy less stuff seems to be catching on. Credit... Supported by By Cara Buckley Photographs by Ryan David Brown Reporting from ...

In and of itself it doesn't mean much; sickle cell disease isn't exactly a major market. The fact that the U.S. Food and Drug Administration approved any CRISPR (clustered regularly interspaced short ...

Adeola Adeosun is the Newsweek Weekend Night Editor based in Atlanta, Georgia. Her focus is reporting on U.S. national news, politics and trends. Adeola joined Newsweek in 2024 and has previously ...